M&A Deal Summary

Seelos Therapeutics Acquires Apricus Biosciences

On January 24, 2019, Seelos Therapeutics acquired life science company Apricus Biosciences

Acquisition Highlights
  • This is Seelos Therapeutics’ 1st transaction in the Life Science sector.
  • This is Seelos Therapeutics’ 1st transaction in the United States.
  • This is Seelos Therapeutics’ 1st transaction in California.

M&A Deal Summary
Date 2019-01-24
Target Apricus Biosciences
Sector Life Science
Buyer(s) Seelos Therapeutics
Deal Type Add-on Acquisition
Advisor(s) Canaccord Genuity (Financial)
Latham & Watkins (Legal)

Target

Apricus Biosciences

San Diego, California, United States
Apricus Biosciences is a specialty pharmaceutical company with commercial products and a broad pipeline across numerous therapeutic classes. Apricus Biosciences was founded in 1987 and is based in San Diego, California.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Seelos Therapeutics

New York, New York, United States
Category Company
Founded 2016
Sector Life Science
Employees15
Revenue 40M USD (2023)
DESCRIPTION

Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders.Seelos Therapeutics was founded in 2016 and is based in New York.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal